The landscape of dementia analysis has developed dramatically with the advent of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Even though these technological innovations depict outstanding progress in understanding neur